OMNICYTE

omnicyte-logo

Omnicyte is a biotechnology company that develops targeted treatments for cancer therapy. The company develops a proprietary Immuno-Oncology Platform Technology for recombinant targeted immunomodulators, ovarian cancer indication, small cell lung cancer, and multiple additional indications.

#People #Financial #Website #More

OMNICYTE

Industry:
Biotechnology Health Care Product Research

Founded:
2012-01-01

Address:
Branford, Connecticut, United States

Country:
United States

Website Url:
http://www.omnicyte.com

Status:
Active

Contact:
1 (917) 439-7479

Email Addresses:
[email protected]

Total Funding:
366 K USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Content Delivery Network Euro GStatic Google Static Content COVID-19 Wix Wix Bookings


Current Employees Featured

peter-leonardi_image

Peter Leonardi
Peter Leonardi Co-Founder and CEO @ Omnicyte
Co-Founder and CEO
2012-01-01

not_available_image

Angel Pellicer
Angel Pellicer Co-Founder @ Omnicyte
Co-Founder

Founder


not_available_image

Angel Pellicer

peter-leonardi_image

Peter Leonardi

Investors List

national-science-foundation_image

National Science Foundation

National Science Foundation investment in Grant - Omnicyte

connecticut-innovations_image

Connecticut Innovations

Connecticut Innovations investment in Convertible Note - Omnicyte

Official Site Inspections

http://www.omnicyte.com

  • Host name: unalocated.63.wixsite.com
  • IP address: 185.230.63.171
  • Location: Ashburn United States
  • Latitude: 39.018
  • Longitude: -77.539
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20147

Loading ...

More informations about "Omnicyte"

About Us | OMNICYTE

Founder and CEO of OmniCyte. Dr. Leonardiโ€™s previous positions include: CFO of Protein Sciences a private biotech company (sold to Sanofi $750M), Director at Five Prime Advisors (a โ€ฆSee details»

Omnicyte - Crunchbase Company Profile & Funding

Omnicyte is a biotechnology company that develops targeted treatments for cancer therapy. The company develops a proprietary Immuno-Oncology Platform Technology for recombinant โ€ฆSee details»

Home | Finding Targeted Life-Saving Treatments For Patients

OmniCyte is a pre-clinical biotech company addressing significant unmet needs in cancer. top of page. Home. About Us. Development. Presentation. Contact. More. Proprietary Technology โ€ฆSee details»

Omnicyte Company Profile 2024: Valuation, Funding & Investors

Omnicyte General Information Description. Developer of an immuno-oncology platform designed to offer targeted treatments for unmet needs in cancer therapy. The company's platform โ€ฆSee details»

OmniCyte - BioCT

OmniCyte is a preclinical stage, immunology based, biotechnology company located in Branford Connecticut. The company was founded with a focus on developing targeted treatments to โ€ฆSee details»

Omnicyte - Contacts, Employees, Board Members, Advisors

Omnicyte is a biotechnology company that develops targeted treatments for cancer therapy.See details»

OmniCyte, LLC Company Profile | Guilford, CT - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for OmniCyte, LLC of Guilford, CT. Get the latest business insights from Dun & Bradstreet.See details»

OmniCyte - Products, Competitors, Financials, Employees, โ€ฆ

Headquarters Location. 23 Business Park Drive OmniCyte LLC. Branford, Connecticut, 06405, United States +1 (917) 439-7479See details»

Omnicyte - Crunchbase

Omnicyte is a biotechnology company that develops targeted treatments for cancer therapy.See details»

OmniCyte - Overview, News & Similar companies | ZoomInfo.com

Mar 21, 2024 Who is OmniCyte. OmniCyte is a preclinical stage biotechnology company focused on developing targeted treatments for unmet needs in cancer therapy. and multiple add itional โ€ฆSee details»

OmniCyte - BIO International Convention | BIO

Jun 7, 2023 The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... Additional โ€ฆSee details»

OmniCyte, LLC - VentureRadar

OmniCyte is developing its own proprietary Immuno-Oncology Platform Technology for ? Recombinant targeted immunomodulators (co-stimulators) ... Dansk Biotek Unknown n/a โ€ฆSee details»

OmniCyte | Branford, CT, USA Startup - Gust

OmniCyte is an immunology company leveraging our proprietary targeted platform technology to develop therapeutics for oncology, infectious & autoimmune diseases. Stage Prototype Ready โ€ฆSee details»

Contact Us - OMNICYTE

80 Fifth Avenue 10th Floor, New York NY 10011 Business Park Drive, Branford CT 06405 Email: [email protected] Tel: +1 (917) 439-7479See details»

Omnicyte - Funding, Financials, Valuation & Investors - Crunchbase

Omnicyte is a biotechnology company that develops targeted treatments for cancer therapy. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. ...See details»

OmniCyte Awarded NSF Phase II SBIR Grant to Develop a Next โ€ฆ

Mar 21, 2024 In addition to the SARS-CoV-2 vaccine program, OmniCyteโ€™s lead program is an ovarian cancer therapeutic, an HIV vaccine and an autoimmune disease program. This NSF โ€ฆSee details»

Home | Finding Targeted Life-Saving Treatments For Patients With โ€ฆ

OmniCyte is a pre-clinical biotech company addressing significant unmet needs in cancer. OmniCyte is a pre-clinical biotech company addressing significant unmet needs in cancer. top โ€ฆSee details»

A novel SARS-CoV-2 subunit vaccine engineered on an immune โ€ฆ

Research and Development, OmniCyte LLC, Guilford, CT, USA ABSTRACT While there are several SARS-CoV-2 vaccines currently available, additional options must be provided that are โ€ฆSee details»

Omnicyte - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Organization. Omnicyte . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 3. ... This year, Omnicyte โ€ฆSee details»

linkstock.net © 2022. All rights reserved